Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
YungShin Global Holding Co's 1-Year ROIIC % for the quarter that ended in Mar. 2026 was 16.84%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for YungShin Global Holding Co's 1-Year ROIIC % or its related term are showing as below:
TPE:3705's 1-Year ROIIC % is ranked better than 65.55% of 958
companies
in the Drug Manufacturers industry
Industry Median: 1.43
vs TPE:3705: 16.84
YungShin Global Holding Co (TPE:3705) 1-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
YungShin Global Holding Co 1-Year ROIIC % Related Terms
YungShin Global Holding Co 1-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, YungShin Global Holding Co's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YungShin Global Holding Co 1-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, YungShin Global Holding Co's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where YungShin Global Holding Co's 1-Year ROIIC % falls into.
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( 844.1268 (Mar. 2026) - 1092.6096 (Mar. 2025) )
/
( 7751.2 (Mar. 2026) - 9226.376 (Mar. 2025) )
=
-248.4828
/
-1475.176
=
16.84%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
YungShin Global Holding Co (TPE:3705) has a 1-Year ROIIC % of 16.84 as of Mar. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on YungShin Global Holding Co and its competitors. According to the industry distribution chart, YungShin Global Holding Co ranks #330 out of 958 companies in the Drug Manufacturers industry, placing it in the top 34.4%.
Is YungShin Global Holding Co's 1-Year ROIIC % too high?
YungShin Global Holding Co's current 1-Year ROIIC % is 16.84. The Drug Manufacturers industry median 1-Year ROIIC % is 1.43. YungShin Global Holding Co's value of 16.84 is 1077.6% above this industry median. Based on the distribution chart, YungShin Global Holding Co ranks #330 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, YungShin Global Holding Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does YungShin Global Holding Co's 1-Year ROIIC % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, YungShin Global Holding Co ranks #330 out of 958 companies for 1-Year ROIIC %. This puts YungShin Global Holding Co in the upper half of its industry. The industry median 1-Year ROIIC % is 1.43. YungShin Global Holding Co's value of 16.84 is 1077.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Drug Manufacturers company?
The median 1-Year ROIIC % among Drug Manufacturers companies is 1.43, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. YungShin Global Holding Co's current 1-Year ROIIC % of 16.84 is 1077.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on YungShin Global Holding Co and its competitors. For the Drug Manufacturers industry, the median 1-Year ROIIC % is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. YungShin Global Holding Co's current 1-Year ROIIC % is 16.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YungShin Global Holding Co stock overvalued right now?
Based on GuruFocus' analysis, YungShin Global Holding Co (TPE:3705) is currently considered Fairly Valued. The stock's GF Value™ is NT$55.40, compared to a current price of NT$53.60 — trading 3.2% below its estimated fair value. The current 1-Year ROIIC % is 16.84 and 1077.6% above the Drug Manufacturers industry median of 1.43. YungShin Global Holding Co's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For YungShin Global Holding Co (TPE:3705), the current 1-Year ROIIC % is 16.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is YungShin Global Holding Co (TPE:3705) Overvalued in 2026?
Based on GuruFocus' analysis, YungShin Global Holding Co stock appears to be undervalued.
The current stock price of NT$53.60 is trading 3.2% below its estimated GF Value™ of NT$55.40.
GuruFocus considers YungShin Global Holding Co to be Fairly Valued.
Key valuation signals for TPE:3705:
1-Year ROIIC %: 16.84
GF Value™: NT$55.40 vs. price of NT$53.60 (3.2% below fair value)
Industry Position: 1077.6% above the Drug Manufacturers median (#330 of 958)
No single metric tells the full story. See the TPE:3705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. The company derives revenue from the sale of Human drugs, Health food, Animal drugs, and Others. The company generates the majority of its revenue from Human drugs. Geographically, the company generates the revenue from Taiwan, the USA, Japan, and China, out of which the majority of its revenue is generated from Taiwan.
88GF Score
Get the complete analysis for TPE:3705
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3705 has been successfully added to your 
